Somerville, MA, United States of America

Claire T Wake


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1992-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Claire T. Wake

Introduction

Claire T. Wake is a prominent inventor based in Somerville, MA (US). She has made significant contributions to the field of biotechnology, particularly in the area of human lymphocyte antigen complex. With a total of 3 patents to her name, her work has had a profound impact on diagnostic and therapeutic applications.

Latest Patents

Claire's latest patents focus on DNA sequences coding for the DR beta-chain locus of the human lymphocyte antigen complex. These innovations include polypeptides and diagnostic typing processes related to these DNA sequences. The DNA sequences that code for the beta-chain DR locus are particularly useful in developing simple and efficient typing processes and products. They also facilitate the expression of polypeptides that display immunological or biological activity of the HLA-DR beta-chains. This work is crucial for creating diagnostic, preventive, and therapeutic agents.

Career Highlights

Throughout her career, Claire has worked with notable companies, including Biomerieux SA. Her expertise in biotechnology has allowed her to contribute to advancements in the field, enhancing the understanding and application of human lymphocyte antigens.

Collaborations

Claire has collaborated with esteemed colleagues such as Eric O. Long and Bernard Francois Mach. These partnerships have further enriched her research and development efforts.

Conclusion

Claire T. Wake's innovative work in biotechnology, particularly her patents related to the human lymphocyte antigen complex, showcases her significant contributions to the field. Her research continues to pave the way for advancements in diagnostic and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…